Abstract
Hypoxia is related to poor prognosis because it is associated to chemo- and radioresistance. During recent years the evolution of imaging methods like PET/CT and MRI has meant the appearance of new perspectives with direct implications in radiation therapy. We discuss previous experiences in staging, planning and in the follow-up process with these techniques for measuring tumour hypoxia.
MeSH terms
-
Animals
-
Biomarkers, Tumor / genetics
-
Biomarkers, Tumor / metabolism
-
Fluorodeoxyglucose F18
-
Humans
-
Hypoxia / genetics
-
Hypoxia / metabolism*
-
Immunohistochemistry
-
Molecular Imaging / methods*
-
Neoplasms / diagnosis
-
Neoplasms / metabolism
-
Neoplasms / radiotherapy*
-
Neoplasms / therapy*
-
Positron-Emission Tomography / methods
-
Prognosis
-
Radiotherapy Planning, Computer-Assisted / methods*
-
Tomography, X-Ray Computed / methods
Substances
-
Biomarkers, Tumor
-
Fluorodeoxyglucose F18